Abstract: A method of providing fragrance to a product releasable on exposure of the product to humidity, comprising (a) the encapsulation of fragrance in a particulate matrix by dispersing the fragrance in a solution of the matrix material and spray-drying the dispersion to give fragrance-containing particles; (b) dispersing the particles in an organic liquid non-solvent for the matrix material; and (c) adding the resulting particles to the product. The particles thus treated do not separate so readily from the product, resulting in a longer-lasting fragrance.

Abstract: A method of treating Alzheimer's disease (AD) in a subject includes administering to the subject a therapeutically effective amount of at least one parathyroid hormone type 1 receptor (PTH1R) agonist.

Abstract: The present invention includes methods for the detection of neurotransmission or developmental disorders, including, but not limited to, myasthenia gravis that is seronegative for autoantibodies to the acetylcholine receptor (AChR) and/or muscle specific tyrosine kinase (MuSK), the method including detecting autoantibodies that bind to LRP4, or an epitope thereof. Also included are methods for the treatment of an individual suffering from a neurotransmission disorder, the method including detecting in a bodily fluid of the individual autoantibodies that bind to LRP4, or an epitope thereof, and administering to the patient an effective amount an immunosuppressant and/or another appropriate therapeutic modality. Also included are antibodies that bind to autoantibodies to LRP4 and kits for the detection of neurotransmission or developmental disorders.

Abstract: A method and system for compensating for a doubly selective channel, and a related apparatus are applied to the field of communications technologies. In embodiments of the present invention, a receive end obtains, based on a minimum mean square error between a transmit pilot sequence and a receive pilot sequence, an optimal parameter used in a process of channel compensation and signal modulation, that is, a modulation order and a channel compensation parameter such as a channel compensation matrix. Therefore, according to the embodiments of the present invention, an optimization method is used to apply a banded equalization channel compensation method and a partial FFT transform to a communications system, thereby improving system performance.

Abstract: The present invention includes methods for the detection of neurotransmission or developmental disorders, including, but not limited to, myasthenia gravis that is seronegative for autoantibodies to the acetylcholine receptor (AChR) and/or muscle specific tyrosine kinase (MuSK), the method including detecting autoantibodies that bind to LRP4, or an epitope thereof. Also included are methods for the treatment of an individual suffering from a neurotransmission disorder, the method including detecting in a bodily fluid of the individual autoantibodies that bind to LRP4, or an epitope thereof, and administering to the patient an effective amount an immunosuppressant and/or another appropriate therapeutic modality. Also included are antibodies that bind to autoantibodies to LRP4 and kits for the detection of neurotransmission or developmental disorders.

Abstract: The present invention includes methods for the detection of neurotransmission or developmental disorders, including, but not limited to, myasthenia gravis that is seronegative for autoantibodies to the acetylcholine receptor (AChR) and/or muscle specific tyrosine kinase (MuSK), the method including detecting autoantibodies that bind to LRP4, or an epitope thereof. Also included are methods for the treatment of an individual suffering from a neurotransmission disorder, the method including detecting in a bodily fluid of the individual autoantibodies that bind to LRP4, or an epitope thereof, and administering to the patient an effective amount an immunosuppressant and/or another appropriate therapeutic modality. Also included are antibodies that bind to autoantibodies to LRP4 and kits for the detection of neurotransmission or developmental disorders.

Abstract: A flicker-reduced liquid crystal display panel diminishing resistance-capacitance phenomena includes a plurality of parallel scanning lines and a plurality of parallel data lines, all lines intersecting with each other at the crosses. The liquid crystal display panel further includes a pulse control circuit and a gate driver. The pulse control circuit receives a pulse signal and reduces the time of the pulse signal under control of a control signal, the control signal controlling the start and finish of the time reduction. A reduced pulse signal is output. The gate driver receives the pulse signal which is output and issues scanning signals to the plurality of scanning lines.

Abstract: The invention provides a showerhead water deflector effective for diverting showerhead water from its spray path. The showerhead water deflector includes a water-deflecting means coupled to a mounting device for attaching the water-deflector to a structure in the shower.

Abstract: A gate driver on panel for a thin film transistor (TFT) array substrate includes a substrate, a plurality of gate drive-on-array (GOA) structures, a plurality of capacitors and a plurality of transmission lines electrically coupling the GOA structures and the capacitors together. At least one protection layer made of indium tin oxide which is electrically insulating from all of the GOA structures, the capacitors and the transmission line is formed on a top of the GOA. The at least one protection layer protects at least one of the GOA structures, the capacitors and the transmission lines from being damaged by gold balls and/or fibers in a sealant for connecting the TFT array substrate and a color filter substrate together.

Abstract: A method and system for compensating for a doubly selective channel, and a related apparatus are applied to the field of communications technologies. In embodiments of the present invention, a receive end obtains, based on a minimum mean square error between a transmit pilot sequence and a receive pilot sequence, an optimal parameter used in a process of channel compensation and signal modulation, that is, a modulation order and a channel compensation parameter such as a channel compensation matrix. Therefore, according to the embodiments of the present invention, an optimization method is used to apply a banded equalization channel compensation method and a partial FFT transform to a communications system, thereby improving system performance.

Abstract: A flicker-reduced liquid crystal display panel diminishing resistance-capacitance phenomena includes a plurality of parallel scanning lines and a plurality of parallel data lines, all lines intersecting with each other at the crosses. The liquid crystal display panel further includes a pulse control circuit and a gate driver. The pulse control circuit receives a pulse signal and reduces the time of the pulse signal under control of a control signal, the control signal controlling the start and finish of the time reduction. A reduced pulse signal is output. The gate driver receives the pulse signal which is output and issues scanning signals to the plurality of scanning lines.

Abstract: Compositions that inhibit or block the interaction between Erbin and ErbB2 and methods of their use are provided. Preferred compositions include peptides that inhibit or block Erbin and ErbB2 interaction under physiologic conditions in a subject. One embodiment provides an isolated peptide fragment of ErbB2 including the C-terminal 15 amino acids of ErbB2. The peptide fragment can be about 15 to 27 amino acids in length.

Abstract: The present invention includes methods for the detection of neurotransmission or developmental disorders, including, but not limited to, myasthenia gravis that is seronegative for autoantibodies to the acetylcholine receptor (AChR) and/or muscle specific tyrosine kinase (MuSK), the method including detecting autoantibodies that bind to LRP4, or an epitope thereof. Also included are methods for the treatment of an individual suffering from a neurotransmission disorder, the method including detecting in a bodily fluid of the individual autoantibodies that bind to LRP4, or an epitope thereof, and administering to the patient an effective amount an immunosuppressant and/or another appropriate therapeutic modality. Also included are antibodies that bind to autoantibodies to LRP4 and kits for the detection of neurotransmission or developmental disorders.

Abstract: A shift register for an LCD display includes N shift register units. Each shift register unit outputs a shift signal. An Nth shift register unit includes a waveform-shaping unit electrically coupled to an shift signal output terminal of the Nth register to perform a waveform-shaping operation on the Nth shift signal according to the (N+1)th shift signal output by an (N+1)th shift register, to reduce the feed-through effect which causes display flicker.

Abstract: The present invention includes methods for the detection of neurotransmission or developmental disorders, including, but not limited to, myasthenia gravis that is seronegative for autoantibodies to the acetylcholine receptor (AChR) and/or muscle specific tyrosine kinase (MuSK), the method including detecting autoantibodies that bind to LRP4, or an epitope thereof. Also included are methods for the treatment of an individual suffering from a neurotransmission disorder, the method including detecting in a bodily fluid of the individual autoantibodies that bind to LRP4, or an epitope thereof, and administering to the patient an effective amount an immunosuppressant and/or another appropriate therapeutic modality. Also included are antibodies that bind to autoantibodies to LRP4 and kits for the detection of neurotransmission or developmental disorders.

Abstract: A display panel having a repairing structure has a display region and a periphery circuit region surrounding the display region. At least one scan line, at least one first connection line and a gate driver are positioned on the periphery circuit region. The gate driver is configured to output a gate signal to the scan line via the connection line. The repairing structure comprises a first repairing wire and a driving chip positioned on the periphery circuit region. The driving chip is located at one end of the first repairing wire. The driving chip is configured to output a repairing gate signal to the connection line via the first repairing wire when the gate signal provide to the scan line from the gate driver is abnormal.

Abstract: A shift register for an LCD display includes N shift register units. Each shift register unit outputs a shift signal. An Nth shift register unit includes a waveform-shaping unit electrically coupled to an shift signal output terminal of the Nth register to perform a waveform-shaping operation on the Nth shift signal according to the (N+1)th shift signal output by an (N+1)th shift register, to reduce the feed-through effect which causes display flicker.

Abstract: Compositions that inhibit or block the interaction between Erbin and ErbB2 and methods of their use are provided. Preferred compositions include peptides that inhibit or block Erbin and ErbB2 interaction under physiologic conditions in a subject. One embodiment provides an isolated peptide fragment of ErbB2 including the C-terminal 15 amino acids of ErbB2. The peptide fragment can be about 15 to 27 amino acids in length.

Abstract: Methods and compositions for male or female contraception are provided. The compositions include an effective amount of netrin-1 to reduce or inhibit sperm concentration in semen of males or to inhibit or reduce fusion of male gametes with female gametes in a female subject Still another embodiment provides a method for diagnosing male infertility by determining the amount of netrin-1 in a sample of epididymal fluid or semen from a male subject, comparing the amount of netting-1 in the sample to levels of netrin-1 in samples of epididymal fluid or semen from fertile males, wherein levels of netrin-1 in the sample from the male subject that are higher or lower than levels of netrin-1 in samples from fertile males are indicative of male infertility in the male subject.